UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
82.60 -0.21 (-0.25%) GOLD FUTURES
2,339.60 +1.20 (+0.05%) DOW
37,981.36 -479.56 (-1.25%) Bitcoin GBP
51,440.34 -249.57 (-0.48%)
Sarepta Therapeutics, Inc. (0L35.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:55PM BST
| Previous close | 117.41 |
| Open | 122.35 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 122.35 - 129.15 |
| 52-week range | 55.68 - 155.48 |
| Volume | |
| Avg. volume | 424 |
| Market cap | 105.162M |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.28 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksAnalysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
Multiple insiders secured a larger position in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) shares over the last 12...
Business WireSarepta Therapeutics to Announce First Quarter 2024 Financial Results
CAMBRIDGE, Mass., April 24, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.
© 2024 Yahoo. All rights reserved.